BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24407349)

  • 1. Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.
    Balistreri CR; Candore G; Lio D; Carruba G
    Cancer Gene Ther; 2014 Jan; 21(1):2-11. PubMed ID: 24407349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.
    Kwon EM; Salinas CA; Kolb S; Fu R; Feng Z; Stanford JL; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):923-33. PubMed ID: 21430300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications.
    Balistreri CR; Caruso C; Carruba G; Miceli V; Campisi I; Listì F; Lio D; Colonna-Romano G; Candore G
    Curr Pharm Des; 2010; 16(6):718-24. PubMed ID: 20388081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation in prostate carcinogenesis.
    De Marzo AM; Platz EA; Sutcliffe S; Xu J; Grönberg H; Drake CG; Nakai Y; Isaacs WB; Nelson WG
    Nat Rev Cancer; 2007 Apr; 7(4):256-69. PubMed ID: 17384581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.
    Beuten J; Gelfond JA; Franke JL; Weldon KS; Crandall AC; Johnson-Pais TL; Thompson IM; Leach RJ
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1869-80. PubMed ID: 19505920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men.
    Kopp TI; Friis S; Christensen J; Tjønneland A; Vogel U
    Cancer Genet; 2013; 206(7-8):266-78. PubMed ID: 23880210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
    Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
    Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Santric V; Djokic M; Suvakov S; Pljesa-Ercegovac M; Nikitovic M; Radic T; Acimovic M; Stankovic V; Bumbasirevic U; Milojevic B; Babic U; Dzamic Z; Simic T; Dragicevic D; Savic-Radojevic A
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183092
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
    Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
    Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues.
    Arai S; Shibata Y; Nakamura Y; Kashiwagi B; Uei T; Tomaru Y; Miyashiro Y; Honma S; Hashimoto K; Sekine Y; Ito K; Sasano H; Suzuki K
    Andrology; 2013 Jan; 1(1):169-74. PubMed ID: 23258647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.
    Park JY; Huang Y; Sellers TA
    Methods Mol Biol; 2009; 471():361-85. PubMed ID: 19109789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.
    Alvarez-Cubero MJ; Martinez-Gonzalez LJ; Robles-Fernandez I; Martinez-Herrera J; Garcia-Rodriguez G; Pascual-Geler M; Cozar JM; Lorente JA
    Mol Diagn Ther; 2017 Apr; 21(2):167-178. PubMed ID: 27995550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of prostate cancer: clinical translational opportunities.
    Vecchione A; Gottardo F; Gomella LG; Wildemore B; Fassan Ms; Bragantini E; Pagano F; Baffa R
    J Exp Clin Cancer Res; 2007 Mar; 26(1):25-37. PubMed ID: 17550130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.
    Sun T; Oh WK; Jacobus S; Regan M; Pomerantz M; Freedman ML; Lee GS; Kantoff PW
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2044-50. PubMed ID: 21900597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.
    Langeberg WJ; Tahir SA; Feng Z; Kwon EM; Ostrander EA; Thompson TC; Stanford JL
    Prostate; 2010 Jun; 70(9):1020-35. PubMed ID: 20209490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the CYP17 gene is associated with prostate cancer risk.
    Gsur A; Bernhofer G; Hinteregger S; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
    Int J Cancer; 2000 Aug; 87(3):434-7. PubMed ID: 10897051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and prostate cancer.
    Vasto S; Carruba G; Candore G; Italiano E; Di Bona D; Caruso C
    Future Oncol; 2008 Oct; 4(5):637-45. PubMed ID: 18922121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer.
    Wang S; Clarke PAG; Davis R; Mumuni S; Kwabi-Addo B
    Cytokine; 2016 Oct; 86():110-118. PubMed ID: 27500645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.